0001678852-20-000001.txt : 20200917
0001678852-20-000001.hdr.sgml : 20200917
20200917094000
ACCESSION NUMBER: 0001678852-20-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20200917
DATE AS OF CHANGE: 20200917
EFFECTIVENESS DATE: 20200917
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Palleon Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001678852
IRS NUMBER: 474541546
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-375741
FILM NUMBER: 201180270
BUSINESS ADDRESS:
STREET 1: 266 SECOND AVENUE, 2ND FLOOR
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 857 285 5900
MAIL ADDRESS:
STREET 1: 266 SECOND AVENUE, 2ND FLOOR
CITY: WALTHAM
STATE: MA
ZIP: 02451
FORMER COMPANY:
FORMER CONFORMED NAME: Palleon Pharma Inc.
DATE OF NAME CHANGE: 20160706
D
1
primary_doc.xml
X0708
D
LIVE
0001678852
Palleon Pharmaceuticals Inc.
266 SECOND AVENUE, 2ND FLOOR
WALTHAM
MA
MASSACHUSETTS
02451
857-285-5900
DELAWARE
Palleon Pharma Inc.
Corporation
true
2015
James
W.
Broderick
266 Second Avenue, 2nd Floor
Waltham
MA
MASSACHUSETTS
02451
Executive Officer
Director
William
Burkoth
266 Second Avenue, 2nd Floor
Waltham
MA
MASSACHUSETTS
02451
Director
Rajeev
Dadoo
266 Second Avenue, 2nd Floor
Waltham
MA
MASSACHUSETTS
02451
Director
Stephen
Hoffman
266 Second Avenue, 2nd Floor
Waltham
MA
MASSACHUSETTS
02451
Director
Karan
Takhar
266 Second Avenue, 2nd Floor
Waltham
MA
MASSACHUSETTS
02451
Director
Eric
Xiao
266 Second Avenue, 2nd Floor
Waltham
MA
MASSACHUSETTS
02451
Director
John
Hennessy
266 Second Avenue, 2nd Floor
Waltham
MA
MASSACHUSETTS
02451
Executive Officer
Biotechnology
Decline to Disclose
- 06b
false
2020-09-02
false
true
false
0
100000007
100000007
0
false
7
0
0
0
The Issuer will use proceeds of the offering for general working capital purposes which may include payments to its executive officers and other employees in the ordinary course of business.
false
Palleon Pharmaceuticals Inc.
/s/James W. Broderick
James W. Broderick
President
2020-09-16